Lv5
1390 积分 2024-03-12 加入
Resmetirom, the first FDA-approved drug for MASH: From drug discovery and action mechanisms to clinical trials
30天前
已完结
MAFLD: a ferroptotic disease
1个月前
已完结
Lactobacillus collinoides JCM1123T: effects on mouse plasma cholesterol and isoflavonoids in the caecum
1个月前
已完结
High-Fat Diet Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites
1个月前
已完结
Tumor microenvironment heterogeneity and progression mechanisms in intrahepatic cholangiocarcinoma: A study based on single-cell and spatial transcriptomic sequencing
1个月前
已完结
DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing
1个月前
已完结
MAFLD: a ferroptotic disease
2个月前
已完结
Gut microbiome as a therapeutic target for liver diseases
2个月前
已完结
Targeting TBXAS1: a novel target of daidzein in alleviating APAP-induced hepatic injury
2个月前
已完结
Daidzein reprograms EP300/CREBBP-deficient immune evasion via targeting the PPARγ–ANGPT4/Tie2 axis in hypopharyngeal squamous cell carcinoma
2个月前
已完结
皖公网安备34019202002308
